These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36951214)

  • 21. Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10.
    Liu T; Woo JA; Bukhari MZ; Wang X; Yan Y; Buosi SC; Ermekbaeva A; Sista A; Kotsiviras P; LePochat P; Chacko A; Zhao X; Kang DE
    Acta Neuropathol Commun; 2022 Jul; 10(1):95. PubMed ID: 35787294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
    Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
    Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
    Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43
    Bargsted L; Medinas DB; Martínez Traub F; Rozas P; Muñoz N; Nassif M; Jerez C; Catenaccio A; Court FA; Hetz C; Matus S
    Sci Rep; 2017 Oct; 7(1):14266. PubMed ID: 29079747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and Phenotypic Spectrum of Amyotrophic Lateral Sclerosis Patients with CCNF Variants from a Large Chinese Cohort.
    Zhao B; Jiang Q; Lin J; Wei Q; Li C; Hou Y; Cao B; Zhang L; Ou R; Liu K; Yang T; Xiao Y; Huang R; Shang H
    Mol Neurobiol; 2023 Jul; 60(7):4150-4160. PubMed ID: 37171577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
    Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
    Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuropathology of FTD associated With ALS.
    Mackenzie IR
    Alzheimer Dis Assoc Disord; 2007; 21(4):S44-9. PubMed ID: 18090423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia.
    Yang X; Sun X; Liu Q; Liu L; Li J; Cai Z; Zhang K; Liu S; He D; Shen D; Liu M; Cui L; Zhang X
    Orphanet J Rare Dis; 2022 Nov; 17(1):404. PubMed ID: 36345033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD.
    Ervilha Pereira P; Schuermans N; Meylemans A; LeBlanc P; Versluys L; Copley KE; Rubien JD; Altheimer C; Peetermans M; Debackere E; Vanakker O; Janssens S; Baets J; Verhoeven K; Lammens M; Symoens S; De Paepe B; Barmada SJ; Shorter J; De Bleecker JL; Bogaert E; Dermaut B
    Acta Neuropathol; 2023 Jun; 145(6):793-814. PubMed ID: 37000196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits.
    Godfrey RK; Alsop E; Bjork RT; Chauhan BS; Ruvalcaba HC; Antone J; Gittings LM; Michael AF; Williams C; Hala'ufia G; Blythe AD; Hall M; Sattler R; Van Keuren-Jensen K; Zarnescu DC
    Acta Neuropathol Commun; 2023 Oct; 11(1):168. PubMed ID: 37864255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of ALS and FTD: implications for translational studies.
    Liščić RM
    Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity.
    Yu Y; Nakagawa T; Morohoshi A; Nakagawa M; Ishida N; Suzuki N; Aoki M; Nakayama K
    Hum Mol Genet; 2019 Oct; 28(20):3486-3497. PubMed ID: 31577344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.
    Higgins NR; Greenslade JE; Wu JJ; Miranda E; Galliciotti G; Monteiro MJ
    Brain Pathol; 2021 Sep; 31(5):e12948. PubMed ID: 33780087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating CCNF mutations in a Taiwanese cohort with amyotrophic lateral sclerosis.
    Tsai PC; Liao YC; Chen PL; Guo YC; Chen YH; Jih KY; Lin KP; Soong BW; Tsai CP; Lee YC
    Neurobiol Aging; 2018 Feb; 62():243.e1-243.e6. PubMed ID: 29102476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
    Afroz T; Chevalier E; Audrain M; Dumayne C; Ziehm T; Moser R; Egesipe AL; Mottier L; Ratnam M; Neumann M; Havas D; Ollier R; Piorkowska K; Chauhan M; Silva AB; Thapa S; Stöhr J; Bavdek A; Eligert V; Adolfsson O; Nelson PT; Porta S; Lee VM; Pfeifer A; Kosco-Vilbois M; Seredenina T
    Neurobiol Dis; 2023 Apr; 179():106050. PubMed ID: 36809847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
    Pasetto L; Grassano M; Pozzi S; Luotti S; Sammali E; Migazzi A; Basso M; Spagnolli G; Biasini E; Micotti E; Cerovic M; Carli M; Forloni G; De Marco G; Manera U; Moglia C; Mora G; Traynor BJ; Chiò A; Calvo A; Bonetto V
    Brain; 2021 Dec; 144(12):3710-3726. PubMed ID: 34972208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.